Viral Vector Production Evolves to Meet Surging Demand

Vector manufacturers may tweak existing AAV systems, boost sheer capacity, and introduce novel host platforms to ensure delivery of gene therapies.

Related Keywords

China ,United States ,Texas ,Weiqiang Liu ,Davidt Curiel ,Logant Collins ,University Of Oxford ,Mckinsey Company ,Drug Administration ,Ferring Pharmaceuticals ,Washington University School Of Medicine ,Matica Biotechnology ,Washington University School ,Published December ,Published May ,Bladder Cancer Gene Therapy ,Injury Increases ,Bio Opens New Cell ,Gene Therapy ,Published March ,Biology Design ,Paradigm Shift ,